Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...

Guggenheim Securities, LLC acted as book-running manager for the offering. H.C. Wainwright & Co. and Lucid Capital Markets, ...

InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting ...

Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...

Health Canada has approved Novartis Canada’s Fabhalta (iptacopan capsules) as the first oral monotherapy to treat adults with ...

Southampton plans to restrict large battery energy storage systems from being built near residential areas. A three-tiered ...

Mass General Brigham researchers discovered a previously unknown mechanism that may drive tissue damage and a new target for drug discovery ...

Peugeot's electric SUVs, the e-3008 and the e-5008, will each receive a new all-wheel drive version in the coming weeks, the ...

Glen Cove will receive two state grants totaling $225,000 to update its infrastructure and city codes. All items will comply ...

Now, over 100 years after the complement system was first described, researchers at Mass General Brigham have discovered that a protein known as granzyme K (GZMK) drives tissue damage and ...

SCHD is a $68B ETF with a 3.57% yield. Explore its strengths, weaknesses, and 2025 reconstitution updates. Click here to read ...